Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -110,715 | -19,973 | -14,479 | -8,044 | -41,873 |
| Depreciation Amortization | 576 | 469 | 413 | 67 | -144 |
| Accounts receivable | N/A | N/A | N/A | N/A | -84 |
| Accounts payable and accrued liabilities | -426 | -864 | -810 | 410 | 525 |
| Other Working Capital | 4,427 | -2,913 | -2,600 | -1,295 | 1,651 |
| Other Operating Activity | 76,359 | 2,938 | 2,228 | 403 | 3,869 |
| Operating Cash Flow | $-29,779 | $-20,343 | $-15,248 | $-8,459 | $-36,056 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -79,807 | 2,000 | 2,000 | 2,000 | 28,310 |
| PPE Investments | -42 | -52 | 1 | 1 | -84 |
| Net Acquisitions | 29,371 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -3 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-50,481 | $1,948 | $2,001 | $2,001 | $28,226 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,726 | 1,726 | 1,726 | N/A | N/A |
| Common Stock Issued | 25,104 | 24,538 | 19,783 | 19,783 | 2,480 |
| Common Stock Repurchased | -44 | -1,303 | -1,193 | N/A | N/A |
| Other Financing Activity | 74,525 | -1,333 | -1,333 | -2,068 | -2,410 |
| Financing Cash Flow | $101,311 | $23,628 | $18,983 | $17,715 | $70 |
| Beginning Cash Position | 24,846 | 24,846 | 24,846 | 24,846 | 32,606 |
| End Cash Position | 45,897 | 30,079 | 30,582 | 36,103 | 24,846 |
| Net Cash Flow | $21,051 | $5,233 | $5,736 | $11,257 | $-7,760 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,779 | -20,343 | -15,248 | -8,459 | -36,056 |
| Capital Expenditure | -42 | -53 | N/A | N/A | -84 |
| Free Cash Flow | -29,821 | -20,396 | -15,248 | -8,459 | -36,140 |